These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9040691

  • 1. Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists.
    Kataoka S, Alam R, Dash PK, Yatsu FM.
    Stroke; 1997 Feb; 28(2):364-9. PubMed ID: 9040691
    [Abstract] [Full Text] [Related]

  • 2. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ, Yun YP.
    Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative effect of L-NAME on rat vascular smooth muscle cells.
    El Mabrouk M, Singh A, Touyz RM, Schiffrin EL.
    Life Sci; 2000 Aug 18; 67(13):1613-23. PubMed ID: 10983855
    [Abstract] [Full Text] [Related]

  • 4. Endothelin and PDGF enhance arachidonic acid release and DNA synthesis in vascular smooth muscle cells.
    Irons CE, Flynn MA, Mok LM, Reynolds EE.
    Am J Physiol; 1996 Jun 18; 270(6 Pt 1):C1642-6. PubMed ID: 8764146
    [Abstract] [Full Text] [Related]

  • 5. Diltiazem, a calcium antagonist, inhibits matrix metalloproteinase-1 (tissue collagenase) production and collagenolytic activity in human vascular smooth muscle cells.
    Wada Y, Kato S, Okamoto K, Izumaru S, Aoyagi S, Morimatsu M.
    Int J Mol Med; 2001 Nov 18; 8(5):561-6. PubMed ID: 11605028
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of vascular smooth muscle cell proliferation by the calcium antagonist clentiazem: role of protein kinase C.
    Alam R, Kataoka S, Alam S, Yatsu F.
    Atherosclerosis; 1996 Oct 25; 126(2):207-19. PubMed ID: 8902146
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers.
    Ko YD, Sachinidis A, Graack GH, Appenheimer M, Wieczorek AJ, Düsing R, Vetter H.
    Clin Investig; 1992 Feb 25; 70(2):113-7. PubMed ID: 1318127
    [Abstract] [Full Text] [Related]

  • 8. TAS-301 blocks receptor-operated calcium influx and inhibits rat vascular smooth muscle cell proliferation induced by basic fibroblast growth factor and platelet-derived growth factor.
    Sasaki E, Nozawa Y, Miyoshi K, Kanda A, Yamasaki Y, Miyake H, Matsuura N.
    Jpn J Pharmacol; 2000 Nov 25; 84(3):252-8. PubMed ID: 11138725
    [Abstract] [Full Text] [Related]

  • 9. Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells.
    Block LH, Emmons LR, Vogt E, Sachinidis A, Vetter W, Hoppe J.
    Proc Natl Acad Sci U S A; 1989 Apr 25; 86(7):2388-92. PubMed ID: 2928338
    [Abstract] [Full Text] [Related]

  • 10. Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation.
    Kim JH, Jin YR, Park BS, Kim TJ, Kim SY, Lim Y, Hong JT, Yoo HS, Yun YP.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1715-21. PubMed ID: 15935146
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
    Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW.
    Circ Res; 2005 Feb 04; 96(2):172-9. PubMed ID: 15625285
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.
    J Cell Physiol; 1997 Jul 04; 172(1):69-78. PubMed ID: 9207927
    [Abstract] [Full Text] [Related]

  • 14. Effects of calcium-antagonists and calmodulin inhibitors on DNA synthesis in cultured rat vascular smooth muscle cells.
    Tomita M, Hirata Y, Takata S, Fujita T.
    Endocrinol Jpn; 1987 Apr 04; 34(2):313-8. PubMed ID: 3497799
    [Abstract] [Full Text] [Related]

  • 15. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells.
    Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J.
    J Biol Chem; 1990 Jun 25; 265(18):10238-43. PubMed ID: 2162342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells.
    Kamiyama M, Utsunomiya K, Taniguchi K, Yokota T, Kurata H, Tajima N, Kondo K.
    J Atheroscler Thromb; 2003 Jun 25; 10(2):117-23. PubMed ID: 12740486
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of BST406, a newly synthesized benzylideneacetophenone derivative, on abnormal vascular smooth muscle cell proliferation.
    Kim TJ, Han HJ, Kim YJ, Jung JC, Yu JY, Lee JJ, Yun YP.
    Biol Pharm Bull; 2010 Jun 25; 33(5):900-4. PubMed ID: 20460774
    [Abstract] [Full Text] [Related]

  • 20. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.
    Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y.
    Circulation; 2002 Jun 18; 105(24):2893-8. PubMed ID: 12070119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.